{
    "analytics_identifier":  null,
    "base_path":  "/guidance/guidance-on-how-variations-to-marketing-authorisations-mas-will-be-handled-after-exit-day-if-the-is-no-deal",
    "content_id":  "4823beac-e290-4110-adf0-9dfdb0281cb8",
    "description":  "How the MHRA will process variations to Marketing Authorisations (MAs) if there\u0027s a no-deal Brexit.",
    "details":  {
                    "attachments":  [

                                    ],
                    "body":  "\u003cdiv class=\"govspeak\"\u003e\n\u003cp\u003eThe guidance describes the approach the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e intends to take to the processing of variations to marketing authorisations after exit day in a no-deal Brexit.\u003c/p\u003e\n\n\u003ch2 id=\"variations-procedures\"\u003e1. Variations Procedures\u003c/h2\u003e\n\u003cp\u003eThe secondary legislation revokes the Variations Regulation (EC) No 1234/2008, as amended, which was immediately binding in the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e and applied immediately before exit day and incorporates in the Human Medicines Regulations 2012 (“\u003cabbr title=\"Human Medicines Regulations\"\u003eHMRs\u003c/abbr\u003e”) the elements of that Regulation that remain applicable in a no-deal Brexit.\u003c/p\u003e\n\n\u003cp\u003eThe procedures detailed under Chapter IIa of that Regulation, which specifically applied to variations to purely national Marketing Authorisations, will continue to apply to both pending and new variations to UK Marketing Authorisations, all of which will be purely national, after exit day and can be found in new regulation 65C and Schedule 10A to the \u003cabbr title=\"Human Medicines Regulations\"\u003eHMRs\u003c/abbr\u003e.\u003c/p\u003e\n\n\u003cp\u003eIn addition, unless specifically highlighted under section 3, the current \u003ca rel=\"external\" href=\"https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-2/c_2013_2008/c_2013_2008_pdf/c_2013_2804_en.pdf\" class=\"govuk-link\"\u003evariations classification guidelines\u003c/a\u003e, which explains the type of variation (Type IA, Type IAIN, Type IB, Type II or Extension) to submit and, where relevant, the conditions to be met and any required supporting documentation, will continue to apply.\u003c/p\u003e\n\n\u003cp\u003eAny extension application should be submitted \u003ca href=\"https://www.gov.uk/guidance/apply-for-a-licence-to-market-a-medicine-in-the-uk\" class=\"govuk-link\"\u003ein accordance with the procedures for new Marketing Authorisations\u003c/a\u003e. The variations classification guidelines will continue to apply until the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e issues any revised guidance in the future.\u003c/p\u003e\n\n\u003cp\u003eThe UK will recognise any Article 5 recommendation published by the Co-ordination group for Mutual recognition and Decentralised procedures – human (\u003cabbr title=\"Co-ordination group for Mutual recognition and Decentralised procedures – human\"\u003eCMDh\u003c/abbr\u003e) before exit day.  Any specific request from a Marketing Authorisation Holder (\u003cabbr title=\"Marketing Authorisation Holder\"\u003eMAH\u003c/abbr\u003e), concerning the classification of a variation, which is still pending (no recommendation) on exit date or is submitted after exit day will need to be submitted directly to the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e, who will issue its own recommendation.\u003c/p\u003e\n\n\u003ch2 id=\"variation-of-a-uk-marketing-authorisation\"\u003e2. Variation of a UK marketing authorisation\u003c/h2\u003e\n\n\u003cp\u003eIf not the case before exit day, all Marketing Authorisations authorised in the UK by the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e will become purely national. Any pending and new variations will therefore only be processed to conclusion after exit as national variations, where the relevant national procedures will be followed.\u003c/p\u003e\n\n\u003cp\u003eAny centrally authorised products (\u003cabbr title=\"Centrally Authorised Products\"\u003eCAPs\u003c/abbr\u003e) which are grandfathered will also be national Marketing Authorisations. Transitional provisions make special arrangements to handle these variations and these are explained in \u003ca href=\"https://www.gov.uk/guidance/converting-centrally-authorised-products-caps-to-uk-marketing-authorisations-mas-in-a-no-deal-scenario-grandfathering-and-managing-lifecycle-ch\" class=\"govuk-link\"\u003eseparate guidance on converting \u003cabbr title=\"Centrally Authorised Products\"\u003eCAPs\u003c/abbr\u003e in the event of a no-deal scenario\u003c/a\u003e.\u003c/p\u003e\n\n\u003ch3 id=\"pending-variations-no-decision\"\u003e2.1. Pending variations (no decision)\u003c/h3\u003e\n\n\u003cp\u003eHow variations that are pending (‘no final decision) on the day we leave the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e would be finalised:\u003c/p\u003e\n\n\u003ch4 id=\"purely-national-marketing-authorisations-not-part-of-any-worksharing-procedure\"\u003ePurely national Marketing Authorisations (not part of any worksharing procedure)\u003c/h4\u003e\n\n\u003cp\u003eThese will be processed to conclusion under the transitional provisions, using the same purely national procedures that were in place prior to Brexit.\u003c/p\u003e\n\n\u003ch4 id=\"uk-marketing-authorisation-covered-under-chapter-ii-of-regulation-ec-no-12342008-variations-to-marketing-authorisations-granted-in-accordance-with-chapter-4-of-the-2001-directive-ie-mutual-recognitiondecentralised-variations-type-ia-type-ib-or-type-ii\"\u003eUK Marketing Authorisation covered under Chapter II of Regulation (EC) No 1234/2008 (variations to marketing authorisations granted in accordance with Chapter 4 of the 2001 Directive i.e. mutual recognition/decentralised variations (Type IA, Type IB or Type II)\u003c/h4\u003e\n\n\u003cp\u003eand\u003c/p\u003e\n\n\u003ch4 id=\"purely-national-marketing-authorisations-before-exit-day-but-part-of-a-worksharing-procedure-under-article-20-of-regulation-ec-no-12342008-type-ib-or-type-ii\"\u003ePurely National Marketing Authorisations before exit day, but part of a Worksharing Procedure under Article 20 of Regulation (EC) No. 1234/2008 (Type IB or Type II)\u003c/h4\u003e\n\n\u003cp\u003eFor variations falling under either of these two scenarios, whether or not the UK was the Reference Member State/Reference Authority (lead) for the procedure, the variation will be processed to its conclusion as a purely national variation. Every effort will be made to ensure that relevant procedural time periods are observed. The ongoing assessment will take into account where in the overall procedure the application has got to on exit day. Therefore, any information previously obtained, and any assessment reported on before exit day will be taken into consideration as part of the UK assessment process.\u003c/p\u003e\n\n\u003ch3 id=\"pending-variations-decision-made\"\u003e2.2. Pending variations (decision made)\u003c/h3\u003e\n\n\u003cp\u003eIn the event that the UK is not the Reference Member State or Reference Authority for a variation procedure and a final decision has already been taken by the lead authority, but not finally processed in the UK before exit day, the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e will implement the agreed outcome of the procedure.\u003c/p\u003e\n\n\u003ch3 id=\"new-variations-submitted-post-exit-day\"\u003e2.3. New variations submitted post exit day\u003c/h3\u003e\n\u003cp\u003eAll new variations submitted after exit day will be processed as purely national variations, according to the same transposed procedures, as were in place prior to Brexit. There will be no provision for worksharing.\u003c/p\u003e\n\n\u003ch2 id=\"points-to-note-for-specific-changes-submitted-post-brexit\"\u003e3. Points to note for specific changes submitted post Brexit\u003c/h2\u003e\n\n\u003ch3 id=\"change-to-finished-product-manufacturer\"\u003e3.1. Change to finished product manufacturer\u003c/h3\u003e\n\n\u003cp\u003eA change in finished product manufacturing site, including as appropriate primary and/or secondary packaging site should be submitted under the relevant sub-change code under B.II.b.1 and be suitably supported. This includes the submission of a copy of the relevant Manufacturing Authorisation or as appropriate a valid good manufacturing practice (\u003cabbr title=\"Good Manufacturing Practice\"\u003eGMP\u003c/abbr\u003e) certificate issued by the UK, or a \u003cabbr title=\"Good Manufacturing Practice\"\u003eGMP\u003c/abbr\u003e certificate (or equivalent document) from the competent authority of a country on the approved country for batch testing list (currently \u003cabbr title=\"European Economic Area\"\u003eEEA\u003c/abbr\u003e Member States, Australia, Canada, Israel, Japan, New Zealand, Switzerland and the \u003cabbr title=\"United States of America\"\u003eUSA\u003c/abbr\u003e).\u003c/p\u003e\n\n\u003cp\u003e\u003ca href=\"https://www.gov.uk/government/publications/list-of-approved-countries-for-authorised-human-medicines-in-a-no-deal-scenario\" class=\"govuk-link\"\u003eMore information about batch testing including a list of approved countries for authorised human medicines in a no-deal scenario\u003c/a\u003e.\u003c/p\u003e\n\n\u003cp\u003eWhere relevant reference to the \u003cabbr title=\"Database of the European Community of manufacturing authorisations and of certificates of Good Manufacturing Practice\"\u003eEudraGMP\u003c/abbr\u003e database will suffice.\u003c/p\u003e\n\n\u003ch3 id=\"change-to-importerbatch-release-sitequality-control-site\"\u003e3.2. Change to importer/batch release site/quality control site\u003c/h3\u003e\n\u003cp\u003eA change in importer/batch release site and/or quality control site should be submitted under the relevant change code under B.II.b.2 and be suitably supported.\u003c/p\u003e\n\n\u003ch4 id=\"importerbatch-release\"\u003e3.2.1. Importer/batch release\u003c/h4\u003e\n\u003cp\u003eThe change should be supported by including a copy of the relevant Manufacturing Authorisation or a valid \u003cabbr title=\"Good Manufacturing Practice\"\u003eGMP\u003c/abbr\u003e certificate issued within the last 3 years (as issued by the UK or a country included on the approved country for import list (currently \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e/\u003cabbr title=\"European Economic Area\"\u003eEEA\u003c/abbr\u003e Member States).\u003c/p\u003e\n\n\u003cp\u003eWhere relevant reference to the \u003cabbr title=\"Database of the European Community of manufacturing authorisations and of certificates of Good Manufacturing Practice\"\u003eEudraGMP\u003c/abbr\u003e database will suffice.\u003c/p\u003e\n\n\u003ch4 id=\"quality-control-site\"\u003e3.2.2. Quality control site\u003c/h4\u003e\n\n\u003cp\u003eThe change should be supported by including a copy of the relevant Manufacturing Authorisation or a valid \u003cabbr title=\"Good Manufacturing Practice\"\u003eGMP\u003c/abbr\u003e certificate (as issued by the UK or a country included on the approved country for batch testing list (currently \u003cabbr title=\"European Economic Area\"\u003eEEA\u003c/abbr\u003e Member States, Australia, Canada, Israel, Japan, New Zealand, and Switzerland. However, \u003ca href=\"https://www.gov.uk/government/publications/list-of-approved-countries-for-authorised-human-medicines-in-a-no-deal-scenario\" class=\"govuk-link\"\u003esee separate guidance considering any specific exclusions\u003c/a\u003e.\u003c/p\u003e\n\n\u003cp\u003eWhere relevant reference to the \u003cabbr title=\"Database of the European Community of manufacturing authorisations and of certificates of Good Manufacturing Practice\"\u003eEudraGMP\u003c/abbr\u003e database will suffice.\u003c/p\u003e\n\n\u003ch3 id=\"change-of-marketing-authorisation-holder-mah\"\u003e3.3. Change of Marketing Authorisation Holder (\u003cabbr title=\"Marketing Authorisation Holder\"\u003eMAH\u003c/abbr\u003e)\u003c/h3\u003e\n\n\u003cp\u003eA change of \u003cabbr title=\"Marketing Authorisation Holder\"\u003eMAH\u003c/abbr\u003e, such as from a company outside the UK to one established in the UK, cannot be done as a variation. That change requires the submission of a Change of Ownership application. It should be noted that after Brexit the \u003cabbr title=\"Marketing Authorisation Holder\"\u003eMAH\u003c/abbr\u003e must be established in the UK within 21 months beginning on exit day.\u003c/p\u003e\n\n\u003cp\u003eHowever, in the interim, the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e will require a contact in the UK. The \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e will contact \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e or \u003cabbr title=\"European Economic Area\"\u003eEEA\u003c/abbr\u003e \u003cabbr title=\"Marketing Authorisation Holders\"\u003eMAHs\u003c/abbr\u003e to ask for details of a UK contact.\u003c/p\u003e\n\n\u003cp\u003eA change to the name/address of the \u003cabbr title=\"Marketing Authorisation Holder\"\u003eMAH\u003c/abbr\u003e can be submitted as a Type IA IN under change code A.1, provided that it is not a change to the legal entity.\u003c/p\u003e\n\n\u003ch3 id=\"change-to-the-location-of-the-pharmacovigilance-systems-master-file-psmf-or-the-qualified-person-for-pharmacovigilance-qppv\"\u003e3.4. Change to the location of the Pharmacovigilance Systems Master File (\u003cabbr title=\"Pharmacovigilance Systems Master File\"\u003ePSMF\u003c/abbr\u003e) or the Qualified Person for Pharmacovigilance (\u003cabbr title=\"Qualified Person for Pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e)\u003c/h3\u003e\n\n\u003cp\u003eAs the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e will no longer have access to the Article 57 database, any change to the \u003cabbr title=\"Qualified Person for Pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e or location of the \u003cabbr title=\"Pharmacovigilance Systems Master File\"\u003ePSMF\u003c/abbr\u003e should be submitted under change code C.I.8.a (Type IA IN), provided the conditions and documentation requirements can be fully met.\u003c/p\u003e\n\n\u003cp\u003eThe \u003cabbr title=\"Qualified Person for Pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e should be established in the UK on day one, although those without a current UK presence will have 21 months beginning on exit day to do so. This temporary exemption will allow an \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e \u003cabbr title=\"Qualified Person for Pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e to assume responsibility for UK \u003cabbr title=\"Marketing Authorisations\"\u003eMAs\u003c/abbr\u003e until a \u003cabbr title=\"Qualified Person for Pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e who resides and operates in the UK can be established.\u003c/p\u003e\n\n\u003ch3 id=\"implementation-of-the-outcome-of-referrals-and-procedures-concerning-psur-or-pass\"\u003e3.5. Implementation of the outcome of referrals and procedures concerning \u003cabbr title=\"Periodic Safety Update Report\"\u003ePSUR\u003c/abbr\u003e or \u003cabbr title=\"Post Authorisation Safety Studies\"\u003ePASS\u003c/abbr\u003e\n\u003c/h3\u003e\n\n\u003cp\u003eWhere the procedure has been finalised before exit day, the outcomes in relation to any required variations will be processed based on the decision already taken. Depending on the nature of the required changes, the variations should be submitted under the relevant main change codes of C.I.3 or B.V.b (usually type IA). The actual submission category will depend on the specific nature of the required changes, taking into consideration if further assessment is required and its level.\u003c/p\u003e\n\n\u003cp\u003eFollowing exit, the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e will be carrying out our own assessments, the outcomes of these assessments will be published together with advice on implementation. Where a variation is required will usually be a Type IA.\u003c/p\u003e\n\n\u003ch3 id=\"submission-of-protocols-and-study-reports-for-post-authorisation-safety-studies-pass\"\u003e3.6. Submission of protocols and study reports for post authorisation safety studies (\u003cabbr title=\"Post Authorisation Safety Studies\"\u003ePASS\u003c/abbr\u003e)\u003c/h3\u003e\n\n\u003cp\u003eAlthough not actually variations, whether or not carried out in relation to a condition of the MA or voluntarily, the protocol and final study reports from safety studies should be submitted to the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e within 12 months of the end of data collection.\u003c/p\u003e\n\n\u003cp\u003eIt has been decided that the most effective way of processing these is according to the Type II variations procedure, and they should be submitted under change code C.I.13. The submission should be accompanied by the appropriate fee, which is the same as that of a Type II complex variation. See also \u003ca href=\"https://www.gov.uk/government/publications/guidance-on-pharmacovigilance-procedures-in-the-event-the-uk-leaves-the-eu-without-a-deal\" class=\"govuk-link\"\u003eseparate guidance on our approach to pharmacovigilance procedures in the event of a no-deal Brexit\u003c/a\u003e.\u003c/p\u003e\n\n\u003ch3 id=\"submission-of-paediatric-study-reports-for-assessment\"\u003e3.7. Submission of paediatric study reports for assessment\u003c/h3\u003e\n\n\u003cp\u003eAfter exit day, holders of a UK marketing authorisation who sponsor a paediatric study (which involves the use in the paediatric population of a medicinal product to which that authorisation relates), must submit the results of this study to the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e within the period of six months from the end of the study. \u003ca href=\"https://www.gov.uk/guidance/completed-paediatric-studies-submission-processing-and-assessment-in-the-event-of-a-no-deal-scenario\" class=\"govuk-link\"\u003e\u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e has issued separate guidance setting out the submission requirements and procedures for assessment of completed paediatric studies\u003c/a\u003e. In cases where an initial appraisal indicates that an assessment is required, the \u003cabbr title=\"Marketing Authorisation Holder\"\u003eMAH\u003c/abbr\u003e will be asked to submit the paediatric data as a Type II complex variation to \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e under change code C.I.13.\u003c/p\u003e\n\n\u003cp\u003eIf the results of a paediatric study have been submitted for assessment to \u003cabbr title=\"European Medicines Agency\"\u003eEMA\u003c/abbr\u003e or \u003cabbr title=\"Co-ordination group for Mutual recognition and Decentralised procedures – human\"\u003eCMDh\u003c/abbr\u003e under Article 46 of Reg.1901/2006/EC prior to exit day \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e will request \u003cabbr title=\"Marketing Authorisation Holders\"\u003eMAHs\u003c/abbr\u003e to submit a Type IB variation to update the product information (\u003cabbr title=\"Product Information\"\u003ePI\u003c/abbr\u003e) if there are proposed changes to the \u003cabbr title=\"Product Information\"\u003ePI\u003c/abbr\u003e that can be directly implemented to relevant UK products following the completion of the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e procedure.\u003c/p\u003e\n\n\u003cp\u003eThis guidance will apply from exit day in line with the \u003ca rel=\"external\" href=\"http://www.legislation.gov.uk/uksi/2019/775/contents/made\" class=\"govuk-link\"\u003eHuman Medicines Regulations (Amendment etc.) (\u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e Exit) Regulations 2019\u003c/a\u003e.\u003c/p\u003e\n\n\u003c/div\u003e",
                    "change_history":  [
                                           {
                                               "note":  "Change of text within Stay up to date box.",
                                               "public_timestamp":  "2019-10-09T12:32:49.000+01:00"
                                           },
                                           {
                                               "note":  "Updated page title and summary to clarify this guidance is about what the process would be after a no-deal Brexit. The rest of the page has not changed.",
                                               "public_timestamp":  "2019-10-03T15:41:39.000+01:00"
                                           },
                                           {
                                               "note":  "First published.",
                                               "public_timestamp":  "2019-03-18T13:56:00.000+00:00"
                                           }
                                       ],
                    "emphasised_organisations":  [
                                                     "240f72bd-9a4d-4f39-94d9-77235cadde8e"
                                                 ],
                    "first_public_at":  "2019-03-18T13:56:00.000+00:00",
                    "political":  false,
                    "related_mainstream_content":  [

                                                   ],
                    "tags":  {
                                 "browse_pages":  [

                                                  ],
                                 "topics":  [
                                                "6d1048f5-9d18-4045-8562-9b85c71b1c9e"
                                            ]
                             }
                },
    "document_type":  "detailed_guide",
    "first_published_at":  "2019-03-18T13:56:00+00:00",
    "links":  {
                  "available_translations":  [
                                                 {
                                                     "api_path":  "/api/content/guidance/guidance-on-how-variations-to-marketing-authorisations-mas-will-be-handled-after-exit-day-if-the-is-no-deal",
                                                     "api_url":  "https://www.gov.uk/api/content/guidance/guidance-on-how-variations-to-marketing-authorisations-mas-will-be-handled-after-exit-day-if-the-is-no-deal",
                                                     "base_path":  "/guidance/guidance-on-how-variations-to-marketing-authorisations-mas-will-be-handled-after-exit-day-if-the-is-no-deal",
                                                     "content_id":  "4823beac-e290-4110-adf0-9dfdb0281cb8",
                                                     "document_type":  "detailed_guide",
                                                     "links":  {

                                                               },
                                                     "locale":  "en",
                                                     "public_updated_at":  "2019-10-09T11:32:49Z",
                                                     "schema_name":  "detailed_guide",
                                                     "title":  "Variations to Marketing Authorisations (MAs) after Brexit",
                                                     "web_url":  "https://www.gov.uk/guidance/guidance-on-how-variations-to-marketing-authorisations-mas-will-be-handled-after-exit-day-if-the-is-no-deal",
                                                     "withdrawn":  true
                                                 }
                                             ],
                  "facet_groups":  [
                                       {
                                           "content_id":  "52435175-82ed-4a04-adef-74c0199d0f46",
                                           "document_type":  "facet_group",
                                           "links":  {

                                                     },
                                           "locale":  "en",
                                           "public_updated_at":  "2019-04-16T08:46:54Z",
                                           "schema_name":  "facet_group",
                                           "title":  "Find EU Exit guidance business",
                                           "withdrawn":  false
                                       }
                                   ],
                  "facet_values":  [
                                       {
                                           "content_id":  "93f5c156-2449-4e52-9e92-aefc73586ffd",
                                           "document_type":  "facet_value",
                                           "links":  {

                                                     },
                                           "locale":  "en",
                                           "public_updated_at":  "2019-04-16T08:46:58Z",
                                           "schema_name":  "facet_value",
                                           "title":  "Pharmaceuticals and clinical trials",
                                           "withdrawn":  false
                                       }
                                   ],
                  "government":  [
                                     {
                                         "api_path":  "/api/content/government/2015-conservative-government",
                                         "api_url":  "https://www.gov.uk/api/content/government/2015-conservative-government",
                                         "base_path":  "/government/2015-conservative-government",
                                         "content_id":  "d4fbc1b9-d47d-4386-af04-ac909f868f92",
                                         "details":  {
                                                         "current":  false,
                                                         "ended_on":  "2016-07-13T00:00:00+00:00",
                                                         "started_on":  "2015-05-08T00:00:00+00:00"
                                                     },
                                         "document_type":  "government",
                                         "links":  {

                                                   },
                                         "locale":  "en",
                                         "title":  "2015 to 2016 Cameron Conservative government",
                                         "web_url":  "https://www.gov.uk/government/2015-conservative-government"
                                     }
                                 ],
                  "organisations":  [
                                        {
                                            "analytics_identifier":  "EA63",
                                            "api_path":  "/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                            "api_url":  "https://www.gov.uk/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                            "base_path":  "/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                            "content_id":  "240f72bd-9a4d-4f39-94d9-77235cadde8e",
                                            "details":  {
                                                            "acronym":  "MHRA",
                                                            "brand":  "department-of-health",
                                                            "default_news_image":  null,
                                                            "logo":  {
                                                                         "crest":  "single-identity",
                                                                         "formatted_title":  "Medicines \u0026amp; Healthcare products\u003cbr/\u003eRegulatory Agency"
                                                                     },
                                                            "organisation_govuk_status":  {
                                                                                              "status":  "live",
                                                                                              "updated_at":  null,
                                                                                              "url":  null
                                                                                          }
                                                        },
                                            "document_type":  "organisation",
                                            "links":  {

                                                      },
                                            "locale":  "en",
                                            "schema_name":  "organisation",
                                            "title":  "Medicines and Healthcare products Regulatory Agency",
                                            "web_url":  "https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                            "withdrawn":  false
                                        }
                                    ],
                  "original_primary_publishing_organisation":  [
                                                                   {
                                                                       "analytics_identifier":  "EA63",
                                                                       "api_path":  "/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                                       "api_url":  "https://www.gov.uk/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                                       "base_path":  "/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                                       "content_id":  "240f72bd-9a4d-4f39-94d9-77235cadde8e",
                                                                       "details":  {
                                                                                       "acronym":  "MHRA",
                                                                                       "brand":  "department-of-health",
                                                                                       "default_news_image":  null,
                                                                                       "logo":  {
                                                                                                    "crest":  "single-identity",
                                                                                                    "formatted_title":  "Medicines \u0026amp; Healthcare products\u003cbr/\u003eRegulatory Agency"
                                                                                                },
                                                                                       "organisation_govuk_status":  {
                                                                                                                         "status":  "live",
                                                                                                                         "updated_at":  null,
                                                                                                                         "url":  null
                                                                                                                     }
                                                                                   },
                                                                       "document_type":  "organisation",
                                                                       "links":  {

                                                                                 },
                                                                       "locale":  "en",
                                                                       "schema_name":  "organisation",
                                                                       "title":  "Medicines and Healthcare products Regulatory Agency",
                                                                       "web_url":  "https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                                       "withdrawn":  false
                                                                   }
                                                               ],
                  "primary_publishing_organisation":  [
                                                          {
                                                              "analytics_identifier":  "EA63",
                                                              "api_path":  "/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                              "api_url":  "https://www.gov.uk/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                              "base_path":  "/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                              "content_id":  "240f72bd-9a4d-4f39-94d9-77235cadde8e",
                                                              "details":  {
                                                                              "acronym":  "MHRA",
                                                                              "brand":  "department-of-health",
                                                                              "default_news_image":  null,
                                                                              "logo":  {
                                                                                           "crest":  "single-identity",
                                                                                           "formatted_title":  "Medicines \u0026amp; Healthcare products\u003cbr/\u003eRegulatory Agency"
                                                                                       },
                                                                              "organisation_govuk_status":  {
                                                                                                                "status":  "live",
                                                                                                                "updated_at":  null,
                                                                                                                "url":  null
                                                                                                            }
                                                                          },
                                                              "document_type":  "organisation",
                                                              "links":  {

                                                                        },
                                                              "locale":  "en",
                                                              "schema_name":  "organisation",
                                                              "title":  "Medicines and Healthcare products Regulatory Agency",
                                                              "web_url":  "https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                              "withdrawn":  false
                                                          }
                                                      ],
                  "suggested_ordered_related_items":  [
                                                          {
                                                              "api_path":  "/api/content/european-structural-investment-funds/sme-support-call-in-greater-lincolnshire-oc14r17p-0654",
                                                              "api_url":  "https://www.gov.uk/api/content/european-structural-investment-funds/sme-support-call-in-greater-lincolnshire-oc14r17p-0654",
                                                              "base_path":  "/european-structural-investment-funds/sme-support-call-in-greater-lincolnshire-oc14r17p-0654",
                                                              "content_id":  "c5954869-2e33-4d40-b62a-805872b47d03",
                                                              "document_type":  "esi_fund",
                                                              "links":  {

                                                                        },
                                                              "locale":  "en",
                                                              "public_updated_at":  "2018-01-29T14:24:40Z",
                                                              "schema_name":  "specialist_document",
                                                              "title":  "CLOSED: SME Support: call in Greater Lincolnshire (OC14R17P 0654) ",
                                                              "web_url":  "https://www.gov.uk/european-structural-investment-funds/sme-support-call-in-greater-lincolnshire-oc14r17p-0654",
                                                              "withdrawn":  false
                                                          }
                                                      ],
                  "taxons":  [
                                 {
                                     "api_path":  "/api/content/health-and-social-care/medicines-medical-devices-blood-marketing-authorisations-variations-licensing",
                                     "api_url":  "https://www.gov.uk/api/content/health-and-social-care/medicines-medical-devices-blood-marketing-authorisations-variations-licensing",
                                     "base_path":  "/health-and-social-care/medicines-medical-devices-blood-marketing-authorisations-variations-licensing",
                                     "content_id":  "f4f28e9d-2050-45fb-ab76-78c0345670da",
                                     "details":  {
                                                     "internal_name":  "Marketing authorisations, variations and licensing guidance [T]",
                                                     "notes_for_editors":  "",
                                                     "visible_to_departmental_editors":  false
                                                 },
                                     "document_type":  "taxon",
                                     "links":  {
                                                   "parent_taxons":  [
                                                                         {
                                                                             "api_path":  "/api/content/health-and-social-care/medicines-medical-devices-blood",
                                                                             "api_url":  "https://www.gov.uk/api/content/health-and-social-care/medicines-medical-devices-blood",
                                                                             "base_path":  "/health-and-social-care/medicines-medical-devices-blood",
                                                                             "content_id":  "cebc01ee-f70a-4397-a552-622e10b62508",
                                                                             "description":  "",
                                                                             "details":  {
                                                                                             "internal_name":  "Medicines and medical devices [T] (level 2, health theme)",
                                                                                             "notes_for_editors":  "",
                                                                                             "visible_to_departmental_editors":  false
                                                                                         },
                                                                             "document_type":  "taxon",
                                                                             "links":  {
                                                                                           "parent_taxons":  [
                                                                                                                 {
                                                                                                                     "api_path":  "/api/content/health-and-social-care",
                                                                                                                     "api_url":  "https://www.gov.uk/api/content/health-and-social-care",
                                                                                                                     "base_path":  "/health-and-social-care",
                                                                                                                     "content_id":  "8124ead8-8ebc-4faf-88ad-dd5cbcc92ba8",
                                                                                                                     "description":  "",
                                                                                                                     "details":  {
                                                                                                                                     "internal_name":  "Health and social care",
                                                                                                                                     "notes_for_editors":  "",
                                                                                                                                     "visible_to_departmental_editors":  true
                                                                                                                                 },
                                                                                                                     "document_type":  "taxon",
                                                                                                                     "links":  {
                                                                                                                                   "root_taxon":  ""
                                                                                                                               },
                                                                                                                     "locale":  "en",
                                                                                                                     "phase":  "live",
                                                                                                                     "public_updated_at":  "2018-09-16T20:30:51Z",
                                                                                                                     "schema_name":  "taxon",
                                                                                                                     "title":  "Health and social care",
                                                                                                                     "web_url":  "https://www.gov.uk/health-and-social-care",
                                                                                                                     "withdrawn":  false
                                                                                                                 }
                                                                                                             ]
                                                                                       },
                                                                             "locale":  "en",
                                                                             "phase":  "live",
                                                                             "public_updated_at":  "2019-02-06T16:16:55Z",
                                                                             "schema_name":  "taxon",
                                                                             "title":  "Medicines, medical devices",
                                                                             "web_url":  "https://www.gov.uk/health-and-social-care/medicines-medical-devices-blood",
                                                                             "withdrawn":  false
                                                                         }
                                                                     ]
                                               },
                                     "locale":  "en",
                                     "phase":  "live",
                                     "public_updated_at":  "2018-08-22T12:56:21Z",
                                     "schema_name":  "taxon",
                                     "title":  "Marketing authorisations, variations and licensing guidance",
                                     "web_url":  "https://www.gov.uk/health-and-social-care/medicines-medical-devices-blood-marketing-authorisations-variations-licensing",
                                     "withdrawn":  false
                                 },
                                 {
                                     "api_path":  "/api/content/government/brexit",
                                     "api_url":  "https://www.gov.uk/api/content/government/brexit",
                                     "base_path":  "/government/brexit",
                                     "content_id":  "d6c2de5d-ef90-45d1-82d4-5f2438369eea",
                                     "description":  "Find out how new Brexit rules apply to things like travel and doing business with Europe.",
                                     "details":  {
                                                     "internal_name":  "Brexit",
                                                     "notes_for_editors":  "",
                                                     "url_override":  "/government/collections/brexit-guidance",
                                                     "visible_to_departmental_editors":  true
                                                 },
                                     "document_type":  "taxon",
                                     "links":  {
                                                   "parent_taxons":  [
                                                                         {
                                                                             "api_path":  "/api/content/government/all",
                                                                             "api_url":  "https://www.gov.uk/api/content/government/all",
                                                                             "base_path":  "/government/all",
                                                                             "content_id":  "e48ab80a-de80-4e83-bf59-26316856a5f9",
                                                                             "description":  "",
                                                                             "details":  {
                                                                                             "internal_name":  "Government",
                                                                                             "notes_for_editors":  "",
                                                                                             "visible_to_departmental_editors":  true
                                                                                         },
                                                                             "document_type":  "taxon",
                                                                             "links":  {
                                                                                           "root_taxon":  [
                                                                                                              {
                                                                                                                  "api_path":  "/api/content/",
                                                                                                                  "api_url":  "https://www.gov.uk/api/content/",
                                                                                                                  "base_path":  "/",
                                                                                                                  "content_id":  "f3bbdec2-0e62-4520-a7fd-6ffd5d36e03a",
                                                                                                                  "document_type":  "homepage",
                                                                                                                  "links":  {

                                                                                                                            },
                                                                                                                  "locale":  "en",
                                                                                                                  "public_updated_at":  "2023-06-28T09:32:34Z",
                                                                                                                  "schema_name":  "homepage",
                                                                                                                  "title":  "GOV.UK homepage",
                                                                                                                  "web_url":  "https://www.gov.uk/",
                                                                                                                  "withdrawn":  false
                                                                                                              }
                                                                                                          ]
                                                                                       },
                                                                             "locale":  "en",
                                                                             "phase":  "live",
                                                                             "public_updated_at":  "2018-09-16T20:29:39Z",
                                                                             "schema_name":  "taxon",
                                                                             "title":  "Government",
                                                                             "web_url":  "https://www.gov.uk/government/all",
                                                                             "withdrawn":  false
                                                                         }
                                                                     ]
                                               },
                                     "locale":  "en",
                                     "phase":  "live",
                                     "public_updated_at":  "2024-11-14T17:47:34Z",
                                     "schema_name":  "taxon",
                                     "title":  "Brexit",
                                     "web_url":  "https://www.gov.uk/government/brexit",
                                     "withdrawn":  false
                                 }
                             ]
              },
    "locale":  "en",
    "phase":  "live",
    "public_updated_at":  "2019-10-09T12:32:49+01:00",
    "publishing_app":  "whitehall",
    "publishing_request_id":  "2672-1631014186.155-10.13.5.96-539",
    "publishing_scheduled_at":  null,
    "rendering_app":  "government-frontend",
    "scheduled_publishing_delay_seconds":  null,
    "schema_name":  "detailed_guide",
    "title":  "Variations to Marketing Authorisations (MAs) after Brexit",
    "updated_at":  "2024-11-14T17:48:25+00:00",
    "withdrawn_notice":  {
                             "explanation":  "\u003cdiv class=\"govspeak\"\u003e\u003cp\u003eFor current information see \u003ca href=\"https://www.gov.uk/guidance/medicines-apply-for-a-variation-to-your-marketing-authorisation\" class=\"govuk-link\"\u003eApply for a variation to your marketing authorisation\u003c/a\u003e\u003c/p\u003e\n\u003c/div\u003e",
                             "withdrawn_at":  "2020-02-24T12:06:14Z"
                         }
}
